Quanterix (QTRX) Competitors $4.55 +0.23 (+5.32%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$4.47 -0.08 (-1.65%) As of 09/5/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock QTRX vs. SIBN, TRNS, EYPT, ALNT, AEHR, CTKB, LAB, SENS, FEIM, and MASSShould you be buying Quanterix stock or one of its competitors? The main competitors of Quanterix include SiBone (SIBN), Transcat (TRNS), Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Aehr Test Systems (AEHR), Cytek Biosciences (CTKB), Standard BioTools (LAB), Senseonics (SENS), Frequency Electronics (FEIM), and 908 Devices (MASS). Quanterix vs. Its Competitors SiBone Transcat Eyepoint Pharmaceuticals Allient Aehr Test Systems Cytek Biosciences Standard BioTools Senseonics Frequency Electronics 908 Devices SiBone (NASDAQ:SIBN) and Quanterix (NASDAQ:QTRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings. Is SIBN or QTRX more profitable? SiBone has a net margin of -12.83% compared to Quanterix's net margin of -56.04%. SiBone's return on equity of -14.20% beat Quanterix's return on equity.Company Net Margins Return on Equity Return on Assets SiBone-12.83% -14.20% -10.38% Quanterix -56.04%-18.41%-14.80% Do analysts rate SIBN or QTRX? SiBone currently has a consensus price target of $23.67, indicating a potential upside of 45.28%. Quanterix has a consensus price target of $11.75, indicating a potential upside of 158.24%. Given Quanterix's higher probable upside, analysts plainly believe Quanterix is more favorable than SiBone.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SiBone 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Quanterix 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 Which has stronger valuation and earnings, SIBN or QTRX? SiBone has higher revenue and earnings than Quanterix. SiBone is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSiBone$185.26M3.79-$30.91M-$0.56-29.09Quanterix$137.42M1.54-$38.53M-$1.82-2.50 Which has more risk & volatility, SIBN or QTRX? SiBone has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, Quanterix has a beta of 1.03, meaning that its stock price is 3% more volatile than the S&P 500. Does the media favor SIBN or QTRX? In the previous week, Quanterix had 2 more articles in the media than SiBone. MarketBeat recorded 6 mentions for Quanterix and 4 mentions for SiBone. SiBone's average media sentiment score of 1.71 beat Quanterix's score of 1.35 indicating that SiBone is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SiBone 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Quanterix 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in SIBN or QTRX? 98.1% of SiBone shares are owned by institutional investors. Comparatively, 86.5% of Quanterix shares are owned by institutional investors. 4.0% of SiBone shares are owned by insiders. Comparatively, 6.8% of Quanterix shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummarySiBone beats Quanterix on 11 of the 16 factors compared between the two stocks. Get Quanterix News Delivered to You Automatically Sign up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QTRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QTRX vs. The Competition Export to ExcelMetricQuanterixMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$211.42M$10.95B$5.83B$9.92BDividend YieldN/A1.83%6.70%4.51%P/E Ratio-2.5022.1476.2926.13Price / Sales1.5430.23529.66172.92Price / CashN/A24.5336.9959.28Price / Book0.533.5911.486.09Net Income-$38.53M$212.34M$3.29B$266.51M7 Day PerformanceN/A-2.29%1.28%0.45%1 Month Performance-17.42%10.37%8.56%5.05%1 Year Performance-62.05%-6.65%61.19%26.03% Quanterix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QTRXQuanterix2.4191 of 5 stars$4.55+5.3%$11.75+158.2%-62.1%$211.42M$137.42M-2.50460News CoveragePositive NewsSIBNSiBone3.9816 of 5 stars$16.05-2.1%$23.67+47.5%+7.5%$707.08M$167.18M-28.66350News CoverageTRNSTranscat4.1514 of 5 stars$91.20+0.9%$112.20+23.0%-34.2%$842.72M$278.42M63.781,245News CoveragePositive NewsEYPTEyepoint Pharmaceuticals2.4476 of 5 stars$11.59-2.0%$25.38+118.9%+75.8%$815.41M$43.27M-4.32120News CoveragePositive NewsALNTAllient3.479 of 5 stars$46.59-0.6%$35.00-24.9%+136.7%$794.14M$529.97M54.172,525Positive NewsShort Interest ↓AEHRAehr Test Systems2.3878 of 5 stars$24.59+35.9%N/A+89.1%$541.46M$58.97M-189.1490High Trading VolumeCTKBCytek Biosciences2.0223 of 5 stars$4.11-1.0%$5.60+36.3%-24.2%$527.98M$200.45M-82.20500News CoveragePositive NewsLABStandard BioTools2.6393 of 5 stars$1.24-2.4%$1.55+25.0%-33.0%$485.13M$174.43M-3.88620News CoveragePositive NewsInsider TradeSENSSenseonics2.1972 of 5 stars$0.46-0.3%$1.55+240.1%+41.9%$371.33M$25.47M-3.5190News CoverageFEIMFrequency Electronics1.9116 of 5 stars$30.81+6.2%N/A+130.0%$282.21M$69.81M12.47200News CoverageUpcoming EarningsMASS908 Devices3.5608 of 5 stars$6.27-2.8%$8.00+27.6%+52.4%$231.30M$59.63M-11.6160News CoverageAnalyst Downgrade Related Companies and Tools Related Companies SIBN Alternatives TRNS Alternatives EYPT Alternatives ALNT Alternatives AEHR Alternatives CTKB Alternatives LAB Alternatives SENS Alternatives FEIM Alternatives MASS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QTRX) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quanterix Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Quanterix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
